Clinical Trial Update: Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating lumateperone for acute treatment of mania in bipolar disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Manic Episode

Drugs mentioned

• Caplyta (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Bipolar Disorder, Manic | Phase 3 | Status: RECRUITING